Dr. Yogendrakumar is a Stroke Neurologist at the Ottawa Hospital, an Assistant Professor with the Faculty of Medicine at the University of Ottawa, and an Associate Scientist with the Ottawa Hospital Research Institute.
Dr. Yogendrakumar received his MD from the University of British Columbia, completed his residency in Adult Neurology at the University of Ottawa, and completed both a stroke fellowship and PhD at the University of Melbourne. Dr. Yogendrakumar is an emerging international leader in hyperacute stroke research with a specific interest in thrombolysis and neuroimaging. His work has garnered him several notable awards, including the European Stroke Organization Young Investigator Award, the Paul Dudley White International Scholar Award, and a Canadian Institute of Health Research Fellowship.
Yogendrakumar V, Campbell BCV, Johns HT, Churilov L, Ng FN, Sitton CW, Hassan AE, Abraham MG, Ortega-Guiterrez S, Hussain MS, Chen M, Kasner SE, Sharma G, Guha P, Pujara DK, Shaker F, Lansberg MG, Wechsler LW, Nguyen TN, Fifi JT, Hill MD, Ribo M, Parsons MW, Davis SM, Grotta JC, Albers GW, Sarraj A.
Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled Trial. Stroke. 2025;56(6):1366-1375
Yogendrakumar V, Vandelanotte S, Mistry EA, Hill MD, Coutts SB, Nogueira RG, Nguyen TN, Medcalf RL, Broderick JP, De Meyer SF, Campbell BCV.
Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion.
Stroke. 2024;55(10):2536-2546
Parsons MW,
Yogendrakumar V, Churilov L, Garcia-Esperon C, Campbell BCV, Russell ML, Sharma G, Chen C, Lin L, Chew BL, Ng FC, Deepak A, Choi PMC, Kleinig TJ, Cordato DJ, Wu TY, Fink JN, Ma H, Phan TG, Markus HS, Molina CA, Tsai CH, Lee JT, Jeng JS, Strbian D, Meretoja A, Arenillas JF, Buck BH, Devlin MJ, Brown H, Butcher KS, O’Brien B, Sabet A, Wijeratne T, Bivard A, Grimley RS, Agarwal S, Donnan GA, Davis SM, Miteff F, Spratt NJ, Levi CR.
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation with Perfusion Imaging Selection within 4.5 Hours of Onset (TASTE): a multicentre, randomised, controlled, phase III non-inferiority trial.
Lancet Neurol. 2024; 23(8):775-786
Yogendradkumar V, Beharry J, Churilov L, Alidin K, Ugalde M, Pesavento L, Weir L, Mitchell PJ, Kleinig TJ, Yassi N, Thijs V, Wu TY, Shah DG, Dewey HM, Wijeratne T, Yan B, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM, Campbell BCV.
Tenecteplase Improves Reperfusion Across Time in Large Vessel Stroke.
Annal Neurol. 2023; 93(3):489-499.
Yogendrakumar V, Churilov L, Guha P, Beharry J, Mitchell PJ, Kleinig TJ, Yassi N, Thijs V, Wu TY, Brown H, Dewey HM, Wijeratne T, Yan B, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM, Campbell BCV. T
enecteplase Treatment and Thrombus Characteristics Associated with Early Reperfusion: An EXTEND-IA TNK Trials Analysis.
Stroke. 2023; 54:706–714.
Yogendrakumar V, Ramsay T, Menon B, Qureshi A, Saver JL, Dowlatshahi D.
Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments.
Neurology. 2021;97:e755-e764.
